Literature DB >> 9618123

Prader-Willi syndrome: relationship of adiposity to plasma leptin levels.

A Pietrobelli1, D B Allison, M S Faith, L Beccaria, L Bosio, G Chiumello, L A Campfield, S B Heymsfield.   

Abstract

OBJECTIVE: Prader-Willi syndrome (PWS) is an autosomal dominant disorder involving the proximal long arm of chromosome 15, in which obesity is common. However, there is limited information on the underlying physiological mechanisms promoting obesity in this population. We tested whether there was a significant positive association between leptin and total body fat (TBF) in subjects with PWS, and whether this association was stronger among subjects with than without PWS. RESEARCH METHODS AND PROCEDURES: We studied 21 PWS patients and 64 non-PWS controls on whom we measured serum leptin, total body fat, glucose, insulin, and resting energy expenditure. We tested whether the slope of the regression line between leptin and TBF (in kg), measured by dual energy X-ray absorptiometry, was the same for PWS patients and non-PWS controls.
RESULTS: Regression analyses indicated that the leptin-TBF association was significantly stronger among PWS patients. In contrast, the slope of the leptin-body mass index association did not significantly differ between PWS patients and non-PWS controls. None of the other outcome variables showed associations with leptin. DISCUSSION: Results suggest that the role of leptin in promoting obesity may be greater among subjects with PWS than among non-PWS controls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618123     DOI: 10.1002/j.1550-8528.1998.tb00337.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  4 in total

1.  Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome.

Authors:  Merlin G Butler; Douglas C Bittel; Zohreh Talebizadeh
Journal:  J Pediatr Endocrinol Metab       Date:  2004-09       Impact factor: 1.634

2.  Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome.

Authors:  Roja Motaghedi; Elizabeth G Lipman; Jeannette E Hogg; Paul J Christos; Maria G Vogiatzi; Moris A Angulo
Journal:  Eur J Med Genet       Date:  2010-10-20       Impact factor: 2.708

3.  Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome.

Authors:  Merlin G Butler; Douglas C Bittel
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

4.  Leptin levels among prepubertal children with Down syndrome compared with their siblings.

Authors:  Sheela N Magge; Kristen L O'Neill; Justine Shults; Virginia A Stallings; Nicolas Stettler
Journal:  J Pediatr       Date:  2007-10-24       Impact factor: 4.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.